<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>potency Archives - Marijuana Impact Group</title>
	<atom:link href="https://themig.org/tag/potency/feed/" rel="self" type="application/rss+xml" />
	<link>https://themig.org/tag/potency/</link>
	<description>Marijuana Impact Group</description>
	<lastBuildDate>Tue, 12 Mar 2024 19:48:55 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.3</generator>

<image>
	<url>https://themig.org/wp-content/uploads/2025/05/cropped-favicon_MIG-1-32x32.png</url>
	<title>potency Archives - Marijuana Impact Group</title>
	<link>https://themig.org/tag/potency/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Commercial Cannabis: Tested levels of THC lower than labeling on package </title>
		<link>https://themig.org/commercial-cannabis-tested-levels-of-thc-lower-than-labeling-on-package/</link>
		
		<dc:creator><![CDATA[admin]]></dc:creator>
		<pubDate>Tue, 12 Mar 2024 19:48:51 +0000</pubDate>
				<category><![CDATA[Public Health and Safety]]></category>
		<category><![CDATA[cannabis]]></category>
		<category><![CDATA[Colorado]]></category>
		<category><![CDATA[Delta-9]]></category>
		<category><![CDATA[legalization]]></category>
		<category><![CDATA[Marijuana]]></category>
		<category><![CDATA[potency]]></category>
		<category><![CDATA[THC]]></category>
		<guid isPermaLink="false">https://www.thenmi.org/?p=7623</guid>

					<description><![CDATA[<p>The National Marijuana Initiative (NMI) in a partnership with the University of Mississippi, Natural Products Laboratory, conducted research into the actual THC potency of cannabis products in the commercial marketplace.  University researchers found that 70% of the commercial cannabis flower they analyzed, failed to meet the claimed THC potency level, as labeled, when sold. When compared [&#8230;]</p>
<p>The post <a href="https://themig.org/commercial-cannabis-tested-levels-of-thc-lower-than-labeling-on-package/">Commercial Cannabis: Tested levels of THC lower than labeling on package </a> appeared first on <a href="https://themig.org">Marijuana Impact Group</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph">The National Marijuana Initiative (NMI) in a partnership with the University of Mississippi, Natural Products Laboratory, conducted research into the actual THC potency of cannabis products in the commercial marketplace.  University researchers found that 70% of the commercial cannabis flower they analyzed, failed to meet the claimed THC potency level, as labeled, when sold. When compared to the claimed THC levels, the actual THC levels detected in the vast majority of tested samples were lower by as much as 20 – 160 percent.  Only one sample had slightly more THC than as labeled. </p>



<p class="wp-block-paragraph">University of Mississippi researchers conducted analysis on a total of 107 raw cannabis flower samples collected from Colorado, Oregon, and two areas in California (San Diego and Central Valley). Random samples were purchased by law enforcement, at commercial adult use dispensaries, and submitted to the laboratory for analysis. Researchers recorded the claimed THC concentration associated to that sample. Analysis was then conducted to determine (1) the actual THC value and (2) to assess the accuracy of THC content expressed on labeling. A detected THC content that was within plus (+) or minus (-) 20 percent of the claimed potency when sold was considered as an acceptable variance. </p>



<p class="wp-block-paragraph">Researchers noted that the lack of accurate labeling of cannabinoids, such as Delta-9 THC, being consumed by the public, creates a risk of, “… excessive consumption, improper dosing, and acute adverse events. Therefore, it is essential to determine the accuracy and reliability of the labeling in order to promote informed decision making and responsible use of cannabis products.”</p>



<p class="wp-block-paragraph">Read time. &lt; 15 minutes</p>



<p class="wp-block-paragraph">Photo: unsplash.com / Hopman, M.</p>



<div class="wp-block-buttons is-layout-flex wp-block-buttons-is-layout-flex">
<div class="wp-block-button"><a class="wp-block-button__link has-white-color has-text-color has-link-color wp-element-button" href="http://themig.org/wp-content/uploads/2024/03/Evaluation-of-Dispensaries-Cannabis-Flowers-for-Accuracy-of-Labeling-of-Cannabinoids-Content-.pdf" style="border-radius:0px" target="_blank" rel="noreferrer noopener">DOWNLOAD FULL REPORT</a></div>
</div>
<p>The post <a href="https://themig.org/commercial-cannabis-tested-levels-of-thc-lower-than-labeling-on-package/">Commercial Cannabis: Tested levels of THC lower than labeling on package </a> appeared first on <a href="https://themig.org">Marijuana Impact Group</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Dr. LaTisha Bader: &#8220;Women and Weed&#8221; on 10-16-23 (60 minute video)</title>
		<link>https://themig.org/dr-latisha-bader-women-and-weed-on-10-16-23-60-minute-video/</link>
		
		<dc:creator><![CDATA[admin]]></dc:creator>
		<pubDate>Mon, 16 Oct 2023 19:32:15 +0000</pubDate>
				<category><![CDATA[Marijuana Presentations]]></category>
		<category><![CDATA[cannabis]]></category>
		<category><![CDATA[CBD]]></category>
		<category><![CDATA[Colorado]]></category>
		<category><![CDATA[depression]]></category>
		<category><![CDATA[legalization]]></category>
		<category><![CDATA[Marijuana]]></category>
		<category><![CDATA[potency]]></category>
		<category><![CDATA[pregnancy]]></category>
		<category><![CDATA[THC]]></category>
		<category><![CDATA[vaping]]></category>
		<category><![CDATA[Women]]></category>
		<guid isPermaLink="false">https://www.thenmi.org/?p=7371</guid>

					<description><![CDATA[<p>Click on &#8220;Watch on YouTube&#8221;</p>
<p>The post <a href="https://themig.org/dr-latisha-bader-women-and-weed-on-10-16-23-60-minute-video/">Dr. LaTisha Bader: &#8220;Women and Weed&#8221; on 10-16-23 (60 minute video)</a> appeared first on <a href="https://themig.org">Marijuana Impact Group</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph">Click on &#8220;Watch on YouTube&#8221;</p>



<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"><div class="wp-block-embed__wrapper">
<iframe title="Dr. LaTisha Bader: NMI Lecture on &quot;Women and Weed&quot; (101523 Minnesota ATOP)" width="660" height="371" src="https://www.youtube.com/embed/_WO5pSXIju8?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div></figure>
<p>The post <a href="https://themig.org/dr-latisha-bader-women-and-weed-on-10-16-23-60-minute-video/">Dr. LaTisha Bader: &#8220;Women and Weed&#8221; on 10-16-23 (60 minute video)</a> appeared first on <a href="https://themig.org">Marijuana Impact Group</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>The Medical Marijuana Card:  Is it the answer for pain or first domino toward addiction?</title>
		<link>https://themig.org/the-medical-marijuana-card-is-it-the-answer-for-pain-or-first-domino-toward-addiction/</link>
		
		<dc:creator><![CDATA[admin]]></dc:creator>
		<pubDate>Sat, 19 Mar 2022 18:09:26 +0000</pubDate>
				<category><![CDATA[Public Health and Safety]]></category>
		<category><![CDATA[addiction]]></category>
		<category><![CDATA[anxiety]]></category>
		<category><![CDATA[cannabis]]></category>
		<category><![CDATA[CUD]]></category>
		<category><![CDATA[depression]]></category>
		<category><![CDATA[legalization]]></category>
		<category><![CDATA[Marijuana]]></category>
		<category><![CDATA[Medical Marijuana Card]]></category>
		<category><![CDATA[pain]]></category>
		<category><![CDATA[potency]]></category>
		<guid isPermaLink="false">https://www.thenmi.org/?p=6881</guid>

					<description><![CDATA[<p>Pain and anxiety are among the leading reasons why many people seek a Medical Marijuana Card. But is it effective? A new study released in JAMA (03-18-22), by authors Gilman, J. (et.al), suggests getting a medical marijuana card is potentially a faster track to developing a Cannabis Use Disorder (CUD). The authors observed that card [&#8230;]</p>
<p>The post <a href="https://themig.org/the-medical-marijuana-card-is-it-the-answer-for-pain-or-first-domino-toward-addiction/">The Medical Marijuana Card:  Is it the answer for pain or first domino toward addiction?</a> appeared first on <a href="https://themig.org">Marijuana Impact Group</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph">Pain and anxiety are among the leading reasons why many people seek a Medical Marijuana Card. But is it effective? A new study released in JAMA (03-18-22), by authors Gilman, J. (et.al), suggests getting a medical marijuana card is potentially a faster track to developing a Cannabis Use Disorder (CUD). The authors observed that card holders experienced no significant improvement as to their level of pain, anxiety, or depressive symptoms. Individuals in the study groups were allowed to choose what marijuana-based products to consume, the potency levels and frequency of use. At the end of the study, many participants displayed a higher incidence and severity of a CUDs.&nbsp;</p>



<p class="wp-block-paragraph">This study underscores the need for more valid clinical research into marijuana’s benefits and risks when used as a therapeutic agent.</p>



<p class="wp-block-paragraph">Read time: 10 minutes.</p>



<p class="wp-block-paragraph">Photo: Wilson T. / Unsplash.com&nbsp;</p>



<div class="wp-block-buttons is-layout-flex wp-block-buttons-is-layout-flex">
<div class="wp-block-button"><a class="wp-block-button__link no-border-radius" href="http://themig.org/wp-content/uploads/2022/03/JAMA_031822_gilman_2022_MMJ-Card_Pain.pdf" target="_blank" rel="noreferrer noopener">DOWNLOAD FULL ARTICLE</a></div>
</div>



<p class="wp-block-paragraph"></p>
<p>The post <a href="https://themig.org/the-medical-marijuana-card-is-it-the-answer-for-pain-or-first-domino-toward-addiction/">The Medical Marijuana Card:  Is it the answer for pain or first domino toward addiction?</a> appeared first on <a href="https://themig.org">Marijuana Impact Group</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>THC Levels in Med &#038; Rec States: Pain Management</title>
		<link>https://themig.org/thc-levels-in-med-rec-states-pain-management/</link>
		
		<dc:creator><![CDATA[admin]]></dc:creator>
		<pubDate>Fri, 17 Sep 2021 18:59:10 +0000</pubDate>
				<category><![CDATA[Public Health and Safety]]></category>
		<category><![CDATA[Cannabidiol]]></category>
		<category><![CDATA[cannabioinds]]></category>
		<category><![CDATA[CBD]]></category>
		<category><![CDATA[Marijuana]]></category>
		<category><![CDATA[Pain Management]]></category>
		<category><![CDATA[potency]]></category>
		<category><![CDATA[THC]]></category>
		<guid isPermaLink="false">https://www.thenmi.org/?p=6759</guid>

					<description><![CDATA[<p>Pain is the leading reason cited why people use medical marijuana in the United States. Marijuana with low potency levels of tetrahydrocannabinol (THC), i.e. under 5-10%, has shown some efficacy in pain management. However, that’s in stark contrast to the advertised high THC potency levels of marijuana products sold both in medical &#38; recreational dispensaries. [&#8230;]</p>
<p>The post <a href="https://themig.org/thc-levels-in-med-rec-states-pain-management/">THC Levels in Med &#038; Rec States: Pain Management</a> appeared first on <a href="https://themig.org">Marijuana Impact Group</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph">Pain is the leading reason cited why people use medical marijuana in the United States. Marijuana with low potency levels of tetrahydrocannabinol (THC), i.e. under 5-10%, has shown some efficacy in pain management. However, that’s in stark contrast to the advertised high THC potency levels of marijuana products sold both in medical &amp; recreational dispensaries. In both arenas, cannabis based products are being sold with THC levels well in excess of 15% and higher. These higher potency products may be unsuitable for medicinal use. Researchers are unclear of the role that Cannabidiol (CBD), despite its general popularity, actually has in pain management. </p>



<p class="wp-block-paragraph">Researchers (Cash et.al.) examined the advertised potency levels of both THC &amp; CBD products found in specific states with legalized programs. After reviewing over 8,000 products online, the average THC levels in medical states was 19.2% and 21.5% in recreational states. The authors expressed concerns that patients could be at risk for “acute intoxication or long-term side effects.” Given the average THC levels were 2 – 3 times higher than levels found to be effective in previous pain management studies, the authors noted additional risks of adverse mental health outcomes and elevated risks of medical complications from high potency marijuana.  </p>



<p class="wp-block-paragraph">Read time: 10 minutes</p>



<p class="wp-block-paragraph">Photo:&nbsp;</p>



<p class="wp-block-paragraph">Pexels.com / Cottonbro</p>



<div class="wp-block-buttons is-layout-flex wp-block-buttons-is-layout-flex">
<div class="wp-block-button"><a class="wp-block-button__link no-border-radius" href="http://themig.org/wp-content/uploads/2021/09/cannabis-potency-in-medical-and-recreational.pdf" target="_blank" rel="noreferrer noopener">DOWNLOAD FULL ARTICLE</a></div>
</div>
<p>The post <a href="https://themig.org/thc-levels-in-med-rec-states-pain-management/">THC Levels in Med &#038; Rec States: Pain Management</a> appeared first on <a href="https://themig.org">Marijuana Impact Group</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Cannabis Policy: Recommendations from the United States Senate Caucus</title>
		<link>https://themig.org/cannabis-policy-recommendations-from-the-united-states-senate-caucus/</link>
		
		<dc:creator><![CDATA[admin]]></dc:creator>
		<pubDate>Fri, 02 Jul 2021 20:27:59 +0000</pubDate>
				<category><![CDATA[Public Health and Safety]]></category>
		<category><![CDATA[cannabis]]></category>
		<category><![CDATA[Cannabis policy]]></category>
		<category><![CDATA[CBD]]></category>
		<category><![CDATA[impaired driving]]></category>
		<category><![CDATA[Marijuana]]></category>
		<category><![CDATA[potency]]></category>
		<category><![CDATA[Public Health]]></category>
		<category><![CDATA[Public Safety]]></category>
		<category><![CDATA[Research]]></category>
		<category><![CDATA[Senate Caucus]]></category>
		<category><![CDATA[THC]]></category>
		<guid isPermaLink="false">https://www.thenmi.org/?p=6192</guid>

					<description><![CDATA[<p>The United States Senate Caucus recently issued a report titled, “Cannabis Policy, Public Health and Safety, Issues and Recommendations”.&#160;&#160;The report focused on five (5) key areas: (1) Barriers to Researching Cannabis, (2) Impacts of Increased Cannabis Potency, (3) Cannabis Use on the Developing Brain, (4) Unregulated Products and (5) Cannabis Impaired Driving.&#160; The National Marijuana [&#8230;]</p>
<p>The post <a href="https://themig.org/cannabis-policy-recommendations-from-the-united-states-senate-caucus/">Cannabis Policy: Recommendations from the United States Senate Caucus</a> appeared first on <a href="https://themig.org">Marijuana Impact Group</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph">The United States Senate Caucus recently issued a report titled, “<em>Cannabis Policy, Public Health and Safety, Issues and Recommendations</em>”.&nbsp;&nbsp;The report focused on five (5) key areas: (1) Barriers to Researching Cannabis, (2) Impacts of Increased Cannabis Potency, (3) Cannabis Use on the Developing Brain, (4) Unregulated Products and (5) Cannabis Impaired Driving.&nbsp;</p>



<p class="wp-block-paragraph">The National Marijuana Initiative (NMI) created a summary of the Caucus’s 59 page document by highlighting their findings, recommendations and key points with respect to issues stemming from today’s marijuana in America.&nbsp;</p>



<p class="wp-block-paragraph">The role of the Senate Caucus is to encourage government and programs in the private sector, “seeking to expand international cooperation against drug abuse and narcotics trafficking.” To learn more about the Senate Caucus or to read the entire report, go to: <a href="https://www.drugcaucus.senate.gov/HomePage">https://www.drugcaucus.senate.gov/HomePage</a></p>



<p class="wp-block-paragraph">Summary Read Time: &lt;10 minutes</p>



<p class="wp-block-paragraph">Photo: National HIDTA Assistance Center </p>



<div class="wp-block-buttons is-layout-flex wp-block-buttons-is-layout-flex">
<div class="wp-block-button"><a class="wp-block-button__link has-white-color has-text-color" href="http://themig.org/wp-content/uploads/2021/07/Cannabis-Policy-Summary-2021.pdf" style="border-radius:1px" target="_blank" rel="noreferrer noopener">DOWNLOAD SUMMARY</a></div>
</div>



<p class="wp-block-paragraph"></p>
<p>The post <a href="https://themig.org/cannabis-policy-recommendations-from-the-united-states-senate-caucus/">Cannabis Policy: Recommendations from the United States Senate Caucus</a> appeared first on <a href="https://themig.org">Marijuana Impact Group</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Vaping or Smoking: An Early Look at Impairment</title>
		<link>https://themig.org/vaping-or-smoking-an-early-look-at-impairment/</link>
		
		<dc:creator><![CDATA[admin]]></dc:creator>
		<pubDate>Tue, 02 Feb 2021 23:32:11 +0000</pubDate>
				<category><![CDATA[Public Health and Safety]]></category>
		<category><![CDATA[cannabis]]></category>
		<category><![CDATA[drugged driving]]></category>
		<category><![CDATA[impairment]]></category>
		<category><![CDATA[Marijuana]]></category>
		<category><![CDATA[potency]]></category>
		<category><![CDATA[Smoking]]></category>
		<category><![CDATA[THC]]></category>
		<category><![CDATA[vaping]]></category>
		<guid isPermaLink="false">https://www.thenmi.org/?p=5572</guid>

					<description><![CDATA[<p>Currently, there is scant policy or guidance when it comes to either smoking or vaping cannabis. Similarly there is no uniform policy as to the potency levels of products available in today’s public market; nor a complete understanding how the two administration methods (smoking v. vaping) can affect the user.  The 2018 study, “Acute Effects [&#8230;]</p>
<p>The post <a href="https://themig.org/vaping-or-smoking-an-early-look-at-impairment/">Vaping or Smoking: An Early Look at Impairment</a> appeared first on <a href="https://themig.org">Marijuana Impact Group</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph">Currently, there is scant policy or guidance when it comes to either smoking or vaping cannabis. Similarly there is no uniform policy as to the potency levels of products available in today’s public market; nor a complete understanding how the two administration methods (smoking v. vaping) can affect the user. </p>



<p class="wp-block-paragraph">The 2018 study, “Acute Effects of Smoked and Vaporized Cannabis in Healthy Adults Who Infrequently Use Cannabis” published in JAMA, (<em><u>JAMA Network Open. </u></em><em><u>2018;1(7):e184841. doi:10.1001/jamanetworkopen.2018.4841</u></em><em> </em>) by  (T. Spindle et.al.) provides a foundation of knowledge to this topic. This early, small group study, of low THC potency marijuana, (as compared to today’s potency levels), examines that issue. Overall, researchers found that vaporized cannabis, even at this low potency level, had a greater adverse impact with respect to the subjective effects of the drug, the impact to cognitive and psychomotor abilities, as well as to general health issues.  </p>



<p class="wp-block-paragraph">The topics of THC potency levels, different administration methods and issues surrounding impairment all need to be further researched to gain an understanding of the risks that today’s more potent forms of cannabis products represent. </p>



<p class="wp-block-paragraph">Read Time: 10-15 minutes</p>



<p class="wp-block-paragraph">Image: Pexels / W. Pacześ</p>



<div class="wp-block-buttons is-layout-flex wp-block-buttons-is-layout-flex">
<div class="wp-block-button"><a class="wp-block-button__link no-border-radius" href="http://themig.org/wp-content/uploads/2021/02/spindle_2018_oi_1802111.pdf" target="_blank" rel="noreferrer noopener">DOWNLOAD FULL ARTICLE</a></div>
</div>



<p class="wp-block-paragraph"></p>
<p>The post <a href="https://themig.org/vaping-or-smoking-an-early-look-at-impairment/">Vaping or Smoking: An Early Look at Impairment</a> appeared first on <a href="https://themig.org">Marijuana Impact Group</a>.</p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
